Angiogenin protects motoneurons against hypoxic injury

Cell Death and Differentiation

Volumn 16, Issue 9, 2009, Pages 1238-1247

  Sebastia J ^a   Kieran, D ^a   Breen, B ^a   King, M A ^a   Netteland, D F ^a   Joyce, D ^a   Fitzpatrick, S F ^b   Taylor, C T ^b   Prehn, J H M ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; ANGIOGENIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MOTONEURON; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; RECOMBINANT PROTEINS; RIBONUCLEASE, PANCREATIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 69049110867     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.52     Document Type: Article

References (37)

1. Lee K, Roth RA, LaPres JJ. Hypoxia, drug therapy and toxicity. Pharmacol Ther 2007; 113: 229-246.
2. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
3. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008; 409: 19-26.
4. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95 7987-7992.
5. Moroianu J, Riordan JF. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 1994; 91: 1667-1681.
6. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005; 24: 445-456.
7. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S et al. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 2005; 65: 1352-1360.
8. Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P. Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 2001; 11: 137-142.
9. Rajashekhar G, Loganath A, Roy AC, Chong SS, Wong YC. Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J Soc Gynecol Investig 2005; 12: 310-319.
10. Nakamura M, Yamabe H, Osawa H, Nakamura N, Shimada M, Kumasaka R et al. Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant 2006; 21 1489-1495.
11. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C et al ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Gen 2006; 38: 411-413.
12. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2 806-819.
13. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131-138.
14. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413-417.
15. Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W et al. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiol Dis 2004; 17: 21-28.
16. Cronin S, Greenway MJ, Andersen PM, Hardiman O. Screening of hypoxia-inducible genes in sporadic ALS. Amyotroph Lateral Scler 2008; 9: 299-305.
17. Brown WE, Nobile V, Subramanian V, Shapiro R. The mouse angiogenin gene family: Structures of an angiogenin-related gene protein and two pseudogenes. Genomics 1995; 29: 200-206.
18. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT et al Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 1992; 194: 209-221.
19. Dyer KD, Rosenberg HF. The mouse Rnase 4 and Rnase 5/ang 1 locus utilizes dual promoters for tissue-specific expression. Nucleic Acids Res 2005; 33: 1077-1086.
20. Crabtree B, Thiyagarajan N, Prior SH, Wilson P, Iyer S, Ferns T et al Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 2007; 46: 11810-11818.
21. Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 2007; 62: 609-617.
22. Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG et al. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006; 65: 26-36.
23. Bullani RR, Huard B, Viard-Leveugle I, Byers HR, Irmler M, Saurat JH et al. Selective expression of FLIP in malignant melanocytic skin lesions. J Invest Derm 2001; 117: 360-364.
24. O'Reilly JP, Jiang C, Haddad GG. Major differences in response to graded hypoxia between hypoglossal and neocortical neurons. Brain Res 1995; 683: 179-186.
25. 2+ levels in brainstem motoneurones from mouse. J Physiol 2004; 555: 45-59.
26. Murakami T, Ilieva H, Shiote M, Nagata T, Nagano I, Shoji M et al. Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res 2003; 989: 231-237.
27. Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destée A et al. Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS. J Neurol Neurosurg Psychiatry 2006; 77: 255-257.
28. Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch 2005; 450: 363-371.
29. Lu L, Zheng L, Viera L, Suswam E, Li Y, Li X et al. Mutant Cu/ Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci 2007; 27: 7929-7938.
30. Ilzecka J. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis. Acta Clin Croat 2008; 47: 77-79.
31. Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH et al. Elevated serum angiogenin levels in ALS. Neurology 2006; 28: 1833-1836.
32. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 2008; 9: 169-181.
33. Gellera C, Colombrita C, Ticozzi N, Castellotti B, Bragato C, Ratti A et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 2008; 9: 33-40.
34. Subramanian V, Crabtree B, Acharya KR. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 2008; 17: 130-149.
35. Shapiro R, Fox EA, Riordan JF. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry 1989; 28: 1726-1732.
36. Paubel A, Violette J, Amy M, Praline J, Meininger V, Camu W et al. Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 1333-1336.
37. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT. The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem 2003; 278: 40296-40304.